Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Krystal Biotech (KRYS) Change in Inventory: 2023-2024

Historic Change in Inventory for Krystal Biotech (KRYS) over the last 2 years, with Dec 2024 value amounting to $11.9 million.

  • Krystal Biotech's Change in Inventory rose 28.14% to $4.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.7 million, marking a year-over-year increase of 99.88%. This contributed to the annual value of $11.9 million for FY2024, which is 166.08% up from last year.
  • According to the latest figures from FY2024, Krystal Biotech's Change in Inventory is $11.9 million, which was up 166.08% from $4.5 million recorded in FY2023.
  • Krystal Biotech's Change in Inventory's 5-year high stood at $11.9 million during FY2024, with a 5-year trough of $4.5 million in FY2023.
  • Moreover, its 2-year median value for Change in Inventory was $8.2 million (2023), whereas its average is $8.2 million.
  • Data for Krystal Biotech's Change in Inventory shows a peak YoY surged of 166.08% (in 2024) over the last 5 years.
  • Krystal Biotech's Change in Inventory (Yearly) stood at $4.5 million in 2023, then skyrocketed by 166.08% to $11.9 million in 2024.